NIH Offers Licensing Agreements to Commercialize Technologies - NIH makes available a full range of licenses for commercial evaluation and for the sale of commercial products and services. - BioPharm

ADVERTISEMENT

NIH Offers Licensing Agreements to Commercialize Technologies
NIH makes available a full range of licenses for commercial evaluation and for the sale of commercial products and services.


BioPharm International
Volume 20, Issue 3

14. For a list of the NIH Technology Development Coordinators for each of the Institutes and Centers and their contact information, see http://www.ott.nih.gov/nih_staff/tdc.html

15. Conflict of Interest Information and Resources. Washington, DC: NIH. Available from: http://www.nih.gov/about/ethics_COI.htm

16. 15 USC 3710a.

17. 28 USC 209(e).

18. For these and other success stories, see http://www.ott.nih.gov/about_nih/success_stories.html

19. Cooperative Research and Development Agreements and Material Transfer Agreements. Washington, DC: NIH. Available from: http://www.ott.nih.gov/cradas/model_agree.html

20. The Government won a court challenge to keep company proprietary information from disclosure under the Freedom of Information Act. Public Citizen Health Research Group vs. National Institutes of Health and Johnson & Johnson, U.S. Ct D.C., March 12, 2002. Available from: http://www.ott.nih.gov/foia/PCHRGopinion.pdf


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

Bristol-Myers Squibb and Five Prime Therapeutics Collaborate on Development of Immunomodulator
November 26, 2014
Merck Enters into Licensing Agreement with NewLink for Investigational Ebola Vaccine
November 25, 2014
FDA Extends Review of Novartis' Investigational Compound for Multiple Myeloma
November 25, 2014
AstraZeneca Expands Biologics Manufacturing in Maryland
November 25, 2014
GSK Leads Big Pharma in Making Its Medicines Accessible
November 24, 2014
Author Guidelines
Source: BioPharm International,
Click here